Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

LAB

STANDARD BIOTOOLS INC.

Pharmaceutical Preparations · SIC 2834CIK 1162194Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$85.0M
Net Income FY2025
$(75.0M)
EPS (Basic, as reported)
$-0.20
Net Margin FY2025
-87.8%
ROE FY2025
-17.7%
Total Equity
$424.0M
Shares Out
393M
Business description

STANDARD BIOTOOLS INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 104 → 85 -2.2% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023⚑FY2024FY2025
Revenue1041021131171381319810617485
Cost of revenue0(50)(51)(53)——(61)(56)(90)(43)
Gross profit58526264——37508443
Research & development(38)(31)(30)(32)(36)(38)(38)(26)(62)(26)
Selling, general & administrative(93)(80)(80)(84)(98)(99)(115)(88)(157)(110)
Total operating expenses(132)(110)(110)(116)(189)(198)(214)(127)(259)(153)
Operating income(73)(58)(48)(52)(51)(67)(116)(77)(175)(110)
Interest expense(6)(6)(14)(4)(4)(4)(4)(5)(3)0
Interest & investment income——————26209
Other income (expense), net(1)0111017(5)4
Pre-tax income(80)(64)(61)(67)(54)(64)(193)(74)(138)(97)
Income tax expense(4)(3)(2)(2)(1)(4)(3)0(1)(38)
Net income(76)(61)(59)(65)(53)(59)(190)(75)(139)(75)
EPS — basic———($0.97)($0.74)($0.78)($2.43)($0.94)($0.52)($0.20)
EPS — diluted———($0.97)($0.74)($0.78)($2.43)($0.94)($0.52)($0.20)
Shares outstanding — basic (M)———6772767879353382
Shares outstanding — diluted (M)———6772767879353382

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ×4.47 between FY2023 and FY2024 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.